Related Experiment Video
Updated: Jun 25, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
[A primer on the management of antiviral resistance in chronic hepatitis B]
1Service de gastroentérologie et d'hépatologie, CHUV, 1011 Lausanne. Christopher.Doerig@chuv.ch
Abstract:
Treatment options for chronic hepatitis B have significantly expanded over the last decade. Six nucleoside or nucleotide analogs (NA) with activity against the hepatitis B virus are currently available. Prolonged NA treatment is required in many cases to maintain viral suppression, with an inherent risk of the development of antiviral resistance. The purpose of this concise review is to provide an introduction to the prevention, diagnosis and management of antiviral resistance in chronic hepatitis B.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Hepatitis
Retrovirus Life Cycles
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
